Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voice Therapy vs Antireflux Therapy for LPR-related Hoarseness
NCT02530879Phase 4Withdrawn
- Sponsor
- Temple University
- Start
- May 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole, lansoprazole, esomeprazole, ranitidine in laryngopharyngeal reflux (LPR), sponsored by Temple University. Planned start May 2016; status: withdrawn.
02
Drugs
omeprazolelansoprazoleesomeprazoleranitidine
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on NCT02530879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530879.